2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Michael Cotten: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Infusion of autologous cord blood, Placebo - Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns | Phase 2 | Completed | Michael Cotten | 35 | 2017-03-30 | 2024-05-16 |
| Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome Autologous Umbilical Cord Blood - Hypoplastic Left Heart Syndrome | Phase 1 | Terminated | Michael Cotten | 7 | 2011-09-01 | 2024-05-16 |
| Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy infusion of autologous cord blood, Neurodevelopmental outcomes - Neonatal Hypoxic Ischemic Encephalopathy | Phase 1 | Completed | Michael Cotten | 52 | 2008-01-01 | 2024-05-16 |
Hypoxia-Ischemia, Brain (2) · Hypoplastic Left Heart Syndrome (1) · Lymphoma, Follicular (1)
United States (3)